BECHARD, David D,CHAPUT, Nathalie N,DESBOIS, Melanie M,.貝查德,.沙皮,.德布瓦
申请号:
HK16109137.7
公开号:
HK1220918A
申请日:
2016.08.01
申请国别(地区):
HK
年份:
2017
代理人:
摘要:
The present invention relates to a pharmaceutical composition for treating a cancer or an infection in a subject by administrating an amount of an IL-15 derivative conjugate so as to induce a proliferation of natural killer cells (NK cells) which is the same or higher than the one obtained with high dose of interleukin-2 (HDIL-2); eventually associated with a pharmaceutically acceptable carrier.